×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Iterum Therapeutics Plc. (ITRM) NASDAQ

$1.54 (0.05) (-3.15%)

Market Cap: $21.36M

As of 03/28/24 04:00 PM EDT. Market closed.

(ITRM)

Iterum Therapeutics Plc. (ITRM)
NASDAQ

$1.54
(0.05) (-3.15%)

Market Cap: $21.36M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

iterum therapeutics plc is an ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. these products are aimed at combatting the global crisis of multi-drug resistant (mdr) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. iterum’s first product is a novel anti-infective ... read more

iterum therapeutics plc is an ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. these products are aimed at combatting the global crisis of multi-drug resistant (mdr) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. for more information on iterum therapeutics please visit www.iterumtx.com. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
23
URL
Address
.
PRICE CHART FOR ITERUM THERAPEUTICS PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.59
Previous Close
$1.59
Days Range
$1.54 - $1.61
52 week range
$0.62 - $2.50
Volume
228,461
Avg. Volume (30 days)
198,773
Market Cap
$21.36M
Dividend Yield
-
P/E
-
Shares Outstanding
13,435,388
Open
$1.59
Previous Close
$1.59
Days Range
$1.54 - $1.61
52 week range
$0.62 - $2.50
Volume
228,461
Avg. Volume (30 days)
198,773
Market Cap
$21.36M
Dividend Yield
-
P/E
-
Shares Outstanding
13,435,388
FINANCIAL STATEMENTS FOR ITERUM THERAPEUTICS PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ITERUM THERAPEUTICS PLC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Dunne Michael W.DirectorDec 22, 2023 Buy$1.4025,00035,000113,754Dec 27, 2023, 09:00 AM
Dunne Michael W.DirectorDec 18, 2023 Buy$1.8410,00018,44288,754Dec 19, 2023, 04:15 PM
Puttagunta SailajaChief Medical OfficerDec 01, 2023 Option Exercise$2.122,9336,21810,369Dec 04, 2023, 05:00 PM
Dunne Michael W.DirectorNov 22, 2023 Buy$2.0320,00040,69078,754Nov 27, 2023, 05:00 PM
Fishman Corey N.Chief Executive OfficerNov 20, 2023 Buy$1.5910,00015,86354,449Nov 20, 2023, 05:00 PM
Matthews Judith M.Chief Financial OfficerMar 11, 2023 Option Exercise$0.962,8832,7688,135Mar 14, 2023, 06:00 PM
Fishman Corey N.Chief Executive OfficerMar 11, 2023 Option Exercise$0.965,6835,45644,449Mar 14, 2023, 06:00 PM
Puttagunta SailajaChief Medical OfficerDec 02, 2022 Sale$1.323,3654,4424,969Dec 05, 2022, 05:00 PM
Ahrens Brenton KarlDirectorSep 20, 2022 Sale$1.787,24612,9100Sep 20, 2022, 06:00 PM
Ahrens Brenton KarlDirectorSep 19, 2022 Sale$1.7715,00026,4787,246Sep 20, 2022, 06:00 PM
Ahrens Brenton KarlDirectorSep 16, 2022 Sale$1.9015,00028,54222,246Sep 20, 2022, 06:00 PM
Ahrens Brenton KarlDirectorSep 14, 2022 Sale$2.1015,00031,45752,246Sep 15, 2022, 05:36 PM
Ahrens Brenton KarlDirectorSep 13, 2022 Sale$2.1415,00032,11867,246Sep 15, 2022, 05:36 PM
Ahrens Brenton KarlDirectorSep 15, 2022 Sale$2.0215,00030,27237,246Sep 15, 2022, 05:36 PM
Ahrens Brenton KarlDirectorSep 12, 2022 Sale$2.3115,00034,60882,246Sep 12, 2022, 09:01 PM
Ahrens Brenton KarlDirectorSep 09, 2022 Sale$2.3215,00034,72997,246Sep 12, 2022, 09:01 PM
Ahrens Brenton KarlDirectorSep 08, 2022 Sale$2.263,2987,465112,246Sep 12, 2022, 09:01 PM
Dunne Michael W.DirectorSep 07, 2022 Buy$2.2210,00022,20035,576Sep 09, 2022, 06:00 PM
Matthews Judith M.Chief Financial OfficerMar 14, 2022 Sale$0.3163,34019,63565,292Mar 15, 2022, 07:12 PM
Matthews Judith M.Chief Financial OfficerMar 14, 2022 Sale$0.3847,13217,91081,500Mar 15, 2022, 05:01 PM
DENNER ALEXANDER J10% OwnerFeb 12, 2021 Sale$2.2710,619,94924,107,2840Feb 12, 2021, 08:22 PM
DENNER ALEXANDER J10% OwnerFeb 11, 2021 Sale$2.5910,000,00025,899,99910,619,949Feb 12, 2021, 08:22 PM
Fishman Corey N.President & CEOJan 26, 2021 Sale$1.7385,445147,820322,008Jan 27, 2021, 07:35 PM
Dunne Michael W.DirectorJan 26, 2021 Sale$1.7333,14357,337256,355Jan 27, 2021, 07:32 PM
Matthews Judith M.Chief Financial OfficerJan 26, 2021 Sale$1.7333,86858,59228,632Jan 27, 2021, 07:32 PM
Matthews Judith M.Chief Financial OfficerSep 30, 2020 Sale$1.6456,13092,0530Oct 02, 2020, 09:00 PM
Sofinnova Venture Partners IX, L.P.10% OwnerJun 02, 2020 Sale$1.61400,000642,9601,226,514Jun 03, 2020, 08:20 PM
Sofinnova Venture Partners IX, L.P.10% OwnerJun 01, 2020 Sale$1.69100,000169,1201,626,514Jun 03, 2020, 08:20 PM
Kelly David GeorgeDirectorNov 30, 2018 Buy$6.2910,00062,88719,548Dec 04, 2018, 05:48 PM
Chin MarkDirectorOct 30, 2018 Buy$6.1058,000353,8001,089,903Nov 01, 2018, 05:25 PM
Dunne Michael W.Chief Scientific OfficerSep 04, 2018 Buy$10.005005,000147,958Sep 06, 2018, 05:11 PM
Dunne Michael W.Chief Scientific OfficerAug 27, 2018 Buy$10.005005,000147,458Aug 28, 2018, 05:18 PM
Dunne Michael W.Chief Scientific OfficerAug 24, 2018 Buy$10.005005,000146,958Aug 28, 2018, 05:18 PM
Edick Paul RDirectorAug 23, 2018 Buy$10.445005,21925,236Aug 27, 2018, 05:15 PM
Fishman Corey N.President & CEOAug 17, 2018 Buy$8.732,00017,466239,953Aug 21, 2018, 10:44 AM
Chin MarkDirectorMay 30, 2018 Buy$13.00337,6064,388,8781,031,903Jun 01, 2018, 03:37 PM
Lathi Vijay K10% OwnerMay 30, 2018 Buy$13.00278,0623,614,8061,071,688May 31, 2018, 04:54 PM
Lathi Vijay K10% OwnerMay 30, 2018 Buy$13.00384,6154,999,995384,615May 31, 2018, 04:54 PM
HUNT RONALDDirectorMay 30, 2018 Buy$13.00384,6154,999,995384,615May 31, 2018, 04:52 PM
HUNT RONALDDirectorMay 30, 2018 Buy$13.00278,0623,614,8061,071,688May 31, 2018, 04:52 PM
Sofinnova Venture Partners IX, L.P.10% OwnerMay 30, 2018 Buy$13.00500,0006,500,0001,726,514May 30, 2018, 09:59 PM
HEALY JAMESDirectorMay 30, 2018 Buy$13.00500,0006,500,0001,726,514May 30, 2018, 05:32 PM
Malik ShahzadDirectorMay 30, 2018 Buy$13.00228,8402,974,920838,325May 30, 2018, 05:29 PM
Malik ShahzadDirectorMay 30, 2018 Buy$13.008,144105,87229,836May 30, 2018, 05:29 PM
Ahrens Brenton KarlDirectorMay 30, 2018 Buy$13.00506,6566,586,5281,733,170May 30, 2018, 05:26 PM
CANAAN X L.P.DirectorMay 30, 2018 Buy$13.00506,6566,586,5281,733,170May 30, 2018, 05:25 PM
Heron Patrick JDirectorMay 30, 2018 Buy$13.00101,1501,314,950341,155May 30, 2018, 05:15 PM
Heron Patrick JDirectorMay 30, 2018 Buy$13.00354,9494,614,3371,197,161May 30, 2018, 05:15 PM
Matthews Judith M.Chief Financial OfficerMay 30, 2018 Buy$13.004,00052,00056,130May 30, 2018, 05:12 PM
Dunne Michael W.Chief Scientific OfficerMay 30, 2018 Buy$13.002,00026,000146,458May 30, 2018, 05:02 PM
Fishman Corey N.President & CEOMay 30, 2018 Buy$13.003,00039,000237,953May 30, 2018, 05:01 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Dunne Michael W.Director12/22/202335,000
Dunne Michael W.Director12/18/202318,442
Puttagunta SailajaChief Medical Officer12/01/20236,218
Dunne Michael W.Director11/22/202340,690
Fishman Corey N.Chief Executive Officer11/20/202315,863
Matthews Judith M.Chief Financial Officer03/11/20232,768
Fishman Corey N.Chief Executive Officer03/11/20235,456
Puttagunta SailajaChief Medical Officer12/02/20224,442
Ahrens Brenton KarlDirector09/20/202212,910
Ahrens Brenton KarlDirector09/19/202226,478
Ahrens Brenton KarlDirector09/16/202228,542
Ahrens Brenton KarlDirector09/14/202231,457
Ahrens Brenton KarlDirector09/13/202232,118
Ahrens Brenton KarlDirector09/15/202230,272
Ahrens Brenton KarlDirector09/12/202234,608
Ahrens Brenton KarlDirector09/09/202234,729
Ahrens Brenton KarlDirector09/08/20227,465
Dunne Michael W.Director09/07/202222,200
Matthews Judith M.Chief Financial Officer03/14/202219,635
Matthews Judith M.Chief Financial Officer03/14/202217,910
DENNER ALEXANDER J10% Owner02/12/202124,107,284
DENNER ALEXANDER J10% Owner02/11/202125,899,999
Fishman Corey N.President & CEO01/26/2021147,820
Dunne Michael W.Director01/26/202157,337
Matthews Judith M.Chief Financial Officer01/26/202158,592
Matthews Judith M.Chief Financial Officer09/30/202092,053
Sofinnova Venture Partners IX, L.P.10% Owner06/02/2020642,960
Sofinnova Venture Partners IX, L.P.10% Owner06/01/2020169,120
Kelly David GeorgeDirector11/30/201862,887
Chin MarkDirector10/30/2018353,800
Dunne Michael W.Chief Scientific Officer09/04/20185,000
Dunne Michael W.Chief Scientific Officer08/27/20185,000
Dunne Michael W.Chief Scientific Officer08/24/20185,000
Edick Paul RDirector08/23/20185,219
Fishman Corey N.President & CEO08/17/201817,466
Chin MarkDirector05/30/20184,388,878
Lathi Vijay K10% Owner05/30/20183,614,806
Lathi Vijay K10% Owner05/30/20184,999,995
HUNT RONALDDirector05/30/20184,999,995
HUNT RONALDDirector05/30/20183,614,806
Sofinnova Venture Partners IX, L.P.10% Owner05/30/20186,500,000
HEALY JAMESDirector05/30/20186,500,000
Malik ShahzadDirector05/30/20182,974,920
Malik ShahzadDirector05/30/2018105,872
Ahrens Brenton KarlDirector05/30/20186,586,528
CANAAN X L.P.Director05/30/20186,586,528
Heron Patrick JDirector05/30/20181,314,950
Heron Patrick JDirector05/30/20184,614,337
Matthews Judith M.Chief Financial Officer05/30/201852,000
Dunne Michael W.Chief Scientific Officer05/30/201826,000
Fishman Corey N.President & CEO05/30/201839,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ITERUM THERAPEUTICS PLC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC49,9220.00015%6.39%Other
CHANGE IN SHARES OUTSTANDING FOR ITERUM THERAPEUTICS PLC
STOCK BUYBACKS FOR ITERUM THERAPEUTICS PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.75%
1Q
09/30/2023
03/31/2023
2.82%
2Q
09/30/2023
12/31/2022
6.06%
3Q
09/30/2023
09/30/2022
6.59%
4Q
09/30/2023
06/30/2022
6.67%
5Q
09/30/2023
03/31/2022
6.94%
6Q
09/30/2023
12/31/2021
5.56%
7Q
09/30/2023
09/30/2021
-3.30%
8Q
09/30/2023
06/30/2021
-4.40%
9Q
09/30/2023
03/31/2021
60.92%
10Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.75%
1Q
03/31/2023
2.82%
2Q
12/31/2022
6.06%
3Q
09/30/2022
6.59%
4Q
06/30/2022
6.67%
5Q
03/31/2022
6.94%
6Q
12/31/2021
5.56%
7Q
09/30/2021
-3.30%
8Q
06/30/2021
-4.40%
9Q
03/31/2021
60.92%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ITERUM THERAPEUTICS PLC
LOADING...